HHS announces the first drugs for Medicare drug price negotiations

WASHINGTON, D.C., August 30, 2023—The U.S. Department of Health and Human Services (HHS) announced the first 10 prescription drugs covered under Medicare Part D selected for price negotiations which was made possible by the passage of the Inflation Reduction Act. The drugs selected impact approximately 144,000 Medicare Part D enrollees in Washington state to treat […]